$BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC)$ Today, BeiGene stole the spotlight! The company’s optimistic outlook at the J.P. Morgan Healthcare Conference, especially its expectation to achieve positive full-year operating profit in 2025, instantly ignited investor enthusiasm.
A-shares surged over 9%, and Hong Kong shares climbed over 8%, a classic case of "opening high and moving higher"! 🚀 While uncertainties remain, two consecutive quarters of profitability and robust revenue growth inspire confidence in its future.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
